Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Morand-Joubert

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
AIDS Research and Human Retroviruses|January 20, 1996
Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretionsL Belec, A Jean Georges, M C Hallouin, et al.
Blood|August 1, 1997
Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infectionJ J Lefrère, L Morand-Joubert, M Mariotti, et al.
Presse Medicale (Paris, France : 1983)|February 24, 2001
[Predictive factors of virologic response to antiretroviral treatment with a protease inhibitor in HIV infection]J L Meynard, M Guiguet, A Rachline, et al.
Journal of Global Antimicrobial Resistance|November 23, 2016
NRTI-sparing regimens yield higher rates of drug resistance than NRTI-based regimens for HIV-1 treatmentA G Marcelin, B Visseaux, M Wirden, et al.
The Journal of Infectious Diseases|February 1, 1997
Full or partial seroreversion in patients infected by hepatitis C virusJ J Lefrère, S Guiramand, F Lefrère, et al.
Blood|November 14, 1997
Natural history of GBV-C/hepatitis G virus infection through the follow-up of GBV-C/hepatitis G virus-infected blood donors and recipients studied by RNA polymerase chain reaction and anti-E2 serologyJ J Lefrère, P Loiseau, J Maury, et al.
Hepatology (Baltimore, Md.)|September 26, 1997
Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control studyL Serfaty, O Chazouillères, A Poujol-Robert, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 1995
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasmaD Vittecoq, S Chevret, L Morand-Joubert, et al.
Transfusion|August 1, 1996
Quantitation of passively acquired human immunodeficiency virus (HIV) antibodies in AIDS patients transfused with a plasma that is rich in HIV antibodiesJ J Lefrère, F Roudot-Thoraval, D Vittecoq, et al.
Vox Sanguinis|January 1, 1997
Virological and immunological data of AIDS patients treated by passive immunotherapy (transfusions of plasma rich in HIV-1 antibodies)L Morand-Joubert, D Vittecoq, F Roudot-Thoraval, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
AIDS Research and Human Retroviruses|January 20, 1996
Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretionsL Belec, A Jean Georges, M C Hallouin, et al.
Blood|August 1, 1997
Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infectionJ J Lefrère, L Morand-Joubert, M Mariotti, et al.
Presse Medicale (Paris, France : 1983)|February 24, 2001
[Predictive factors of virologic response to antiretroviral treatment with a protease inhibitor in HIV infection]J L Meynard, M Guiguet, A Rachline, et al.
Journal of Global Antimicrobial Resistance|November 23, 2016
NRTI-sparing regimens yield higher rates of drug resistance than NRTI-based regimens for HIV-1 treatmentA G Marcelin, B Visseaux, M Wirden, et al.
The Journal of Infectious Diseases|February 1, 1997
Full or partial seroreversion in patients infected by hepatitis C virusJ J Lefrère, S Guiramand, F Lefrère, et al.
Blood|November 14, 1997
Natural history of GBV-C/hepatitis G virus infection through the follow-up of GBV-C/hepatitis G virus-infected blood donors and recipients studied by RNA polymerase chain reaction and anti-E2 serologyJ J Lefrère, P Loiseau, J Maury, et al.
Hepatology (Baltimore, Md.)|September 26, 1997
Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control studyL Serfaty, O Chazouillères, A Poujol-Robert, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 1995
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasmaD Vittecoq, S Chevret, L Morand-Joubert, et al.
Transfusion|August 1, 1996
Quantitation of passively acquired human immunodeficiency virus (HIV) antibodies in AIDS patients transfused with a plasma that is rich in HIV antibodiesJ J Lefrère, F Roudot-Thoraval, D Vittecoq, et al.
Vox Sanguinis|January 1, 1997
Virological and immunological data of AIDS patients treated by passive immunotherapy (transfusions of plasma rich in HIV-1 antibodies)L Morand-Joubert, D Vittecoq, F Roudot-Thoraval, et al.
Pageof 4